skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Who started the most clinical trials in 2015? Which company is leading when it comes to unapproved drug trials? Which company leads overall? Find out the answers when you download your complimentary Trialtrove Clinical Trails Round-up Infographic. 

Download your complimentary Trialtrove Clinical Trials Round-up Infographic and discover:

  • Trial counts and rankings for top 5 pharma companies, broken down into total trail counts, trial counts for approve drugs, and trial counts for unapproved drugs (including which phase was the most popular for 15 of the top 20 companies when it comes to unapproved drug trials; which companies had the largest trial counts in Phase II, and which companies shifted their volume to Phase III.)
  • Number of clinical trials started in 2015, by phase
  • Distribution of therapeutic areas for top sponsors starting clinical trials in 2015 (including which therapeutic area remains the clear focus)